MCCM MEDICAL COSMETICS pozycji w ofercie ALLPARA do użytku profesjonalnego, kupowanych bezpośrednio i z certyfikatem przy każdej wysyłce.
MCCM Medical Cosmetics HA SENSEI II
MCCM HA SENSEI II is an injectable dermal filler from the MCCM MEDICAL COSMETICS brand (manufacturer Mesosystem S.A., Portugal), developed to restore facial volume and to reduce the severity and volume of wrinkles. It is suitable for qualified practitioners only, for professional use, with clinical data supporting its use in the nasolabial folds. The product is a sterile, non-pyrogenic, bioabsorbable gel of cross-linked hyaluronic acid at 20 mg/mL, made from non-animal hyaluronic acid that is produced by Streptococcus equi fermentation and cross-linked with BDDE. Sterile single-use needles (23G or 27G) are required and are not included.
*Note: This product has market-specific regulatory status. Please contact ALLPARA to confirm current certification and availability for your market before ordering.
Najważniejsze zalety: MCCM Medical Cosmetics HA SENSEI II
- Cross-linked hyaluronic acid dermal filler (20 mg/mL, BDDE, non-animal origin)
- Restores facial volume and redefines facial contours
- Reduces the severity and volume of wrinkles in the nasolabial folds
- Sterile, non-pyrogenic, bioabsorbable gel in a 1 mL prefilled syringe
- Expected duration of approximately 12 months
Wskazania i zastosowanie profesjonalne
Główne wskazania
- Nasolabial folds - reduction of wrinkle severity and volume
- Facial volume restoration
- Management of facial ageing
Zastosowanie profesjonalne
MCCM HA SENSEI 2 is intended strictly for professional use by qualified aesthetic practitioners. It is a Class III injectable dermal filler administered by injection into the mid-dermis of the nasolabial folds using a sterile single-use needle (23G or 27G, not included); clinical data support up to 1 mL per side per session, not exceeding 2 mL per patient per session. It is used in a hospital or private medical office with appropriate aseptic facilities. It is indicated for adults aged 35 and over and must not be used in anyone under 35 or in pregnant or breastfeeding women. Contraindications include known hypersensitivity to hyaluronic acid or streptococcal proteins, allergy to the anaesthetic used, active infection or inflammation at the injection site, autoimmune disease or a history of streptococcal disease, ongoing anticoagulant or immunosuppressive therapy, and more.
Obszary zabiegowe
- Nasolabial folds
Profil pacjenta
Adults aged 35 and over; not for use in anyone under 35 or in pregnant or breastfeeding women. Clinical data are limited in patients older than 65, with Fitzpatrick skin phototypes V and VI, with wrinkles graded below 2 on the Modified Fitzpatrick Wrinkle Scale, with scars, moles or sunburn close to the nasolabial folds, or who have had or will have another aesthetic treatment close to the nasolabial folds; use with caution in these patients.
Jak działa MCCM Medical Cosmetics HA SENSEI II
MCCM HA SENSEI 2 is a cross-linked hyaluronic acid gel (20 mg/mL, BDDE cross-linked, non-animal origin). Once injected, it restores lost volume in the tissue to redefine facial contours and to reduce the severity and volume of wrinkles. The gel is bioabsorbable, with an expected duration of approximately 12 months. After 1 mL per nasolabial fold in one session, improvement was still noticeable at 12 months, with a reduction in fold volume versus baseline in 65.52% of subjects.
Dlaczego warto zamawiać w Allpara
Allpara oferuje oryginalne, sprawdzone produkty MCCM MEDICAL COSMETICS od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z oznakowaniem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z indywidualnym wsparciem posprzedażowym dla Twojego spokoju.
Najczęściej zadawane pytania
Is MCCM HA SENSEI 2 injected or applied topically?
It is an injectable dermal filler. MCCM HA SENSEI 2 is administered by a qualified practitioner using a sterile single-use needle (23G or 27G), not applied topically.
Who can be treated with MCCM HA SENSEI 2?
Adults aged 35 and over. It must not be used in people under 35 or in pregnant or breastfeeding women.
Więcej od Mesosystem
Alternatywy dla kliniki
Kontynuuj przeglądanie
MCCM Medical Cosmetics HA SENSEI II
MCCM HA SENSEI II is an injectable dermal filler from the MCCM MEDICAL COSMETICS brand (manufacturer Mesosystem S.A., Portugal), developed to restore facial volume and to reduce the severity and volume of wrinkles. It is suitable for qualified practitioners only, for professional use, with clinical data supporting its use in the nasolabial folds. The product is a sterile, non-pyrogenic, bioabsorbable gel of cross-linked hyaluronic acid at 20 mg/mL, made from non-animal hyaluronic acid that is produced by Streptococcus equi fermentation and cross-linked with BDDE. Sterile single-use needles (23G or 27G) are required and are not included.
*Note: This product has market-specific regulatory status. Please contact ALLPARA to confirm current certification and availability for your market before ordering.
Najważniejsze zalety: MCCM Medical Cosmetics HA SENSEI II
- Cross-linked hyaluronic acid dermal filler (20 mg/mL, BDDE, non-animal origin)
- Restores facial volume and redefines facial contours
- Reduces the severity and volume of wrinkles in the nasolabial folds
- Sterile, non-pyrogenic, bioabsorbable gel in a 1 mL prefilled syringe
- Expected duration of approximately 12 months
Wskazania i zastosowanie profesjonalne
Główne wskazania
- Nasolabial folds - reduction of wrinkle severity and volume
- Facial volume restoration
- Management of facial ageing
Zastosowanie profesjonalne
MCCM HA SENSEI 2 is intended strictly for professional use by qualified aesthetic practitioners. It is a Class III injectable dermal filler administered by injection into the mid-dermis of the nasolabial folds using a sterile single-use needle (23G or 27G, not included); clinical data support up to 1 mL per side per session, not exceeding 2 mL per patient per session. It is used in a hospital or private medical office with appropriate aseptic facilities. It is indicated for adults aged 35 and over and must not be used in anyone under 35 or in pregnant or breastfeeding women. Contraindications include known hypersensitivity to hyaluronic acid or streptococcal proteins, allergy to the anaesthetic used, active infection or inflammation at the injection site, autoimmune disease or a history of streptococcal disease, ongoing anticoagulant or immunosuppressive therapy, and more.
Obszary zabiegowe
- Nasolabial folds
Profil pacjenta
Adults aged 35 and over; not for use in anyone under 35 or in pregnant or breastfeeding women. Clinical data are limited in patients older than 65, with Fitzpatrick skin phototypes V and VI, with wrinkles graded below 2 on the Modified Fitzpatrick Wrinkle Scale, with scars, moles or sunburn close to the nasolabial folds, or who have had or will have another aesthetic treatment close to the nasolabial folds; use with caution in these patients.
Jak działa MCCM Medical Cosmetics HA SENSEI II
MCCM HA SENSEI 2 is a cross-linked hyaluronic acid gel (20 mg/mL, BDDE cross-linked, non-animal origin). Once injected, it restores lost volume in the tissue to redefine facial contours and to reduce the severity and volume of wrinkles. The gel is bioabsorbable, with an expected duration of approximately 12 months. After 1 mL per nasolabial fold in one session, improvement was still noticeable at 12 months, with a reduction in fold volume versus baseline in 65.52% of subjects.
Dlaczego warto zamawiać w Allpara
Allpara oferuje oryginalne, sprawdzone produkty MCCM MEDICAL COSMETICS z pełną identyfikowalnością partii, produktami z oznakowaniem CE, szybką dostawą na terenie całej UE i fachowym wsparciem posprzedażowym.
Najczęściej zadawane pytania
Is MCCM HA SENSEI 2 injected or applied topically?
It is an injectable dermal filler. MCCM HA SENSEI 2 is administered by a qualified practitioner using a sterile single-use needle (23G or 27G), not applied topically.
Who can be treated with MCCM HA SENSEI 2?
Adults aged 35 and over. It must not be used in people under 35 or in pregnant or breastfeeding women.